Arrowgrass Capital Partners (US)’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-174,569
| Closed | -$16.3M | – | 346 |
|
|
2017
Q2 | $16.3M | Buy |
+174,569
| New | +$16.3M | 0.12% | 89 |
|
|
2016
Q2 | – | Sell |
-50,000
| Closed | -$960K | – | 257 |
|
|
2016
Q1 | $960K | Buy |
+50,000
| New | +$960K | 0.01% | 161 |
|
|
2015
Q3 | – | Sell |
-22,500
| Closed | -$1.98M | – | 301 |
|
|
2015
Q2 | $1.98M | Buy |
+22,500
| New | +$1.98M | 0.03% | 162 |
|
|
2015
Q1 | – | Sell |
-15,000
| Closed | -$840K | – | 342 |
|
|
2014
Q4 | $840K | Sell |
15,000
-5,000
| -25% | -$280K | 0.01% | 179 |
|
|
2014
Q3 | $907K | Buy |
+20,000
| New | +$907K | 0.02% | 157 |
|